Merck Business Finance Contracts & Agreements

94 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Merck & Co., Inc. Common Stock Registered Under Section 12 of the Securities Exchange Act of 1934
Stock Agreements
Merck
Pharmaceuticals
NY
2025
MSD Netherlands Capital B.V. 3.750% Notes Due 2054 Officers’ Certificate under Indenture with Merck & Co., Inc. and U.S. Bank Trust National Association
Note Agreements
Merck
Pharmaceuticals
NY
2024
MSD Netherlands Capital B.V. 3.700% Notes Due 2044 Officers’ Certificate
Note Agreements
Merck
Pharmaceuticals
NY
2024
MSD Netherlands Capital B.V. 3.500% Notes Due 2037 Officers’ Certificate under Indenture with Merck & Co., Inc. and U.S. Bank Trust National Association
Note Agreements
Merck
Pharmaceuticals
NY
2024
MSD Netherlands Capital B.V. 3.250% Notes Due 2032 Officers’ Certificate under Indenture with Merck & Co., Inc. and U.S. Bank Trust National Association
Note Agreements
Merck
Pharmaceuticals
NY
2024
Indenture Agreement among MSD Netherlands Capital B.V., Merck & Co., Inc., and U.S. Bank Trust National Association (May 30, 2024)
Indenture Agreements
Merck
Pharmaceuticals
NY
2024
Merck & Co., Inc. 2023 Non-Qualified Stock Option Grant Terms under 2019 Incentive Stock Plan
Stock Agreements
Merck
Pharmaceuticals
NJ
2024
2021 Performance Share Unit Award Terms under the Merck & Co., Inc. 2019 Stock Incentive Plan
Stock Agreements
Merck
Pharmaceuticals
2024
2019 Non-Qualified Stock Option Grant Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Stock Agreements
Merck
Pharmaceuticals
2024
2017 Non-Qualified Stock Option Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Warrant Agreements
Merck
Pharmaceuticals
NJ
2024
Merck & Co., Inc. 5.150% Notes Due 2063 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. 5.000% Notes Due 2053 Officers’ Certificate
Note Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. 4.900% Notes Due 2044 Officers’ Certificate under Indenture with U.S. Bank Trust National Association
Note Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. 4.500% Notes Due 2033 Officers’ Certificate under Indenture with U.S. Bank Trust National Association
Indenture Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 4.300% Notes Due 2030
Note Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. 4.050% Notes Due 2028 Officers’ Certificate under Indenture
Note Agreements
Merck
Pharmaceuticals
2023
2021 CEO Performance Share Unit Award Terms under the Merck & Co., Inc. 2019 Stock Incentive Plan
Equity Distribution Agreements
Merck
Pharmaceuticals
2023
2021 Performance Share Unit Award Terms under the Merck & Co., Inc. 2019 Stock Incentive Plan
Stock Agreements
Merck
Pharmaceuticals
2023
2020 CEO Performance Share Unit Award Terms under the Merck & Co., Inc. 2019 Stock Incentive Plan
Equity Distribution Agreements
Merck
Pharmaceuticals
2023
2019 CEO Stock Option Grant Terms under Merck & Co., Inc. 2010 Incentive Stock Plan
Equity Distribution Agreements
Merck
Pharmaceuticals
2023
2019 Non-Qualified Stock Option Terms for Merck & Co., Inc. Employees under the 2010 Incentive Stock Plan
Warrant Agreements
Merck
Pharmaceuticals
2023
2017 Non-Qualified Stock Option Terms and Conditions under the Merck & Co., Inc. 2010 Incentive Stock Plan
Warrant Agreements
Merck
Pharmaceuticals
NJ
2023
Merck & Co., Inc. 2022 Non-Qualified Stock Option Grant Terms under 2019 Incentive Stock Plan
Equity Distribution Agreements
Merck
Pharmaceuticals
NJ
2022
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.900% Notes Due 2061
Note Agreements
Merck
Pharmaceuticals
NY
2021
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.750% Notes Due 2051
Note Agreements
Merck
Pharmaceuticals
NY
2021
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.150% Notes Due 2031
Note Agreements
Merck
Pharmaceuticals
NY
2021
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 1.900% Notes Due 2028
Note Agreements
Merck
Pharmaceuticals
NY
2021
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 1.700% Notes Due 2027
Note Agreements
Merck
Pharmaceuticals
NY
2021
2021 Non-Qualified Stock Option Grant Terms under Merck & Co., Inc. 2019 Incentive Stock Plan
Warrant Agreements
Merck
Pharmaceuticals
2021
Description of Merck & Co., Inc. 0.500% Notes Due 2024 and 1.375% Notes Due 2036
Note Agreements
Merck
Pharmaceuticals
NY
2021
Description of Merck & Co., Inc. 1.125% Notes Due 2021, 1.875% Notes Due 2026, and 2.500% Notes Due 2034
Note Agreements
Merck
Pharmaceuticals
NY
2021
Description of Merck & Co., Inc. Common Stock Registered under Section 12 of the Securities Exchange Act of 1934
Stock Agreements
Merck
Pharmaceuticals
2021
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.450% Notes Due 2050 under Indenture
Indenture Agreements
Merck
Pharmaceuticals
NY
2020
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.350% Notes Due 2040
Note Agreements
Merck
Pharmaceuticals
NY
2020
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 1.450% Notes Due 2030 under Indenture
Note Agreements
Merck
Pharmaceuticals
NY
2020
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 0.750% Notes Due 2026
Note Agreements
Merck
Pharmaceuticals
NY
2020
4.000% Notes due 2049 Officers Certificate of the Company dated March 7, 2019, including form of the 2049 Notes
Note Agreements
Merck
Pharmaceuticals
NY
2019
3.900% Notes due 2039 Officers Certificate of the Company dated March 7, 2019, including form of the 2039 Notes
Note Agreements
Merck
Pharmaceuticals
NY
2019
3.400% Notes due 2029 Officers Certificate of the Company dated March 7, 2019, including form of the 2029 Notes
Note Agreements
Merck
Pharmaceuticals
NY
2019
2.900% Notes due 2024 Officers Certificate of the Company dated March 7, 2019, including form of the 2024 Notes
Note Agreements
Merck
Pharmaceuticals
NY
2019